{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:20Z","timestamp":1786119500266,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/gme.0b013e3181e170af","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T06:34:48Z","timestamp":1279607688000},"page":"1182-1187","source":"Crossref","is-referenced-by-count":26,"title":["Androgens associated with advanced glycation end-products in postmenopausal women"],"prefix":"10.1097","volume":"17","author":[{"given":"Evanthia","family":"Diamanti-Kandarakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frangiskos","family":"Economou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Christou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Piperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Creatsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210227","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.fertnstert.2009.06.032","article-title":"Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era.","volume":"92","author":"Perez-Lopez","year":"2009","journal-title":"Fertil Steril"},{"key":"R2-17-20210227","first-page":"2832","article-title":"A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.","volume":"85","author":"Burger","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-17-20210227","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/13697130802416640","article-title":"Androgens in relationship to cardiovascular risk factors in the menopausal transition.","volume":"11","author":"Mesch","year":"2008","journal-title":"Climacteric"},{"key":"R4-17-20210227","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e318185e249","article-title":"Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: Study of Women's Health Across the Nation.","volume":"16","author":"Torrens","year":"2009","journal-title":"Menopause"},{"key":"R5-17-20210227","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/aje\/154.6.489","article-title":"Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation.","volume":"154","author":"Liu","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R6-17-20210227","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/diacare.25.1.55","article-title":"Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study.","volume":"25","author":"Oh","year":"2002","journal-title":"Diabetes Care"},{"key":"R7-17-20210227","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","article-title":"Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-17-20210227","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2009-0740","article-title":"Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease.","volume":"94","author":"Patel","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-17-20210227","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MCA.0b013e32832c459c","article-title":"Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.","volume":"20","author":"Chiang","year":"2009","journal-title":"Coron Artery Dis"},{"key":"R10-17-20210227","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.2337\/dc07-0320","article-title":"Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects.","volume":"30","author":"Uribarri","year":"2007","journal-title":"Diabetes Care"},{"key":"R11-17-20210227","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","article-title":"Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.","volume":"62","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R12-17-20210227","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).","volume":"69","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R13-17-20210227","first-page":"583","article-title":"Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome.","volume":"4","author":"Christakou","year":"2008","journal-title":"Womens Health"},{"key":"R14-17-20210227","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00418-006-0265-3","article-title":"Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries.","volume":"127","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Histochem Cell Biol"},{"key":"R15-17-20210227","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jc.2005-1696","article-title":"Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.","volume":"91","author":"Gonzalez","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-17-20210227","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.mehy.2007.04.049","article-title":"Oxidative stress: does it play a role in the genesis of early glycated proteins?","volume":"70","author":"Selvaraj","year":"2008","journal-title":"Med Hypotheses"},{"key":"R17-17-20210227","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ncpendmet0786","article-title":"Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.","volume":"4","author":"Yan","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R18-17-20210227","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1210\/jc.2009-0910","article-title":"The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women.","volume":"94","author":"Kalyani","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-17-20210227","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1530\/eje.1.02167","article-title":"Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women.","volume":"154","author":"Lambrinoudaki","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"R20-17-20210227","doi-asserted-by":"crossref","first-page":"47376","DOI":"10.1074\/jbc.M301088200","article-title":"Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C -mediated mechanism.","volume":"278","author":"Miele","year":"2003","journal-title":"J Biol Chem"},{"key":"R21-17-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.08.037","article-title":"Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.","volume":"204","author":"Ouyang","year":"2009","journal-title":"Atherosclerosis"},{"key":"R22-17-20210227","doi-asserted-by":"crossref","first-page":"H2059","DOI":"10.1152\/ajpheart.00445.2009","article-title":"Estrogen replacement therapy in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules via a RAGE-related process.","volume":"297","author":"Xu","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R23-17-20210227","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.94.25.13915","article-title":"Tobacco smoke is a source of toxic reactive glycation products.","volume":"94","author":"Cerami","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-17-20210227","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1196\/annals.1333.052","article-title":"Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects.","volume":"1043","author":"Uribarri","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R25-17-20210227","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/gerona\/62.4.427","article-title":"Circulating glycotoxins and dietary advanced glycation end products: two links to inflammatory response, oxidative stress, and aging.","volume":"62","author":"Uribarri","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R26-17-20210227","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jc.2007-1817","article-title":"Clinical review: the role of advanced glycation end products in progression and complications of diabetes.","volume":"93","author":"Goh","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-17-20210227","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.2174\/138161207783018608","article-title":"Advanced glycation: a novel outlook on atherosclerosis.","volume":"13","author":"Price","year":"2007","journal-title":"Curr Pharm Des"},{"key":"R28-17-20210227","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review.","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-201017060-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:22:57Z","timestamp":1786040577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-201017060-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181e170af","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}